Outcomes and feasibility of redo‐TAVR after Sapien 3 Ultra TAVR in extremely‐undersized versus nominally‐sized annuli.

MLA

Tang, Gilbert H. L., et al. “Outcomes and Feasibility of Redo‐TAVR after Sapien 3 Ultra TAVR in Extremely‐undersized versus Nominally‐sized Annuli.” Catheterization & Cardiovascular Interventions, vol. 99, no. 6, May 2022, pp. 1935–44. EBSCOhost, https://doi.org/10.1002/ccd.30146.

APA

Tang, G. H. L., Hooda, A., Zaid, S., Chuang, M., Khera, S., Krishnamoorthy, P., Lerakis, S., Anastasius, M., Ahmad, H. A., Goldberg, J. B., Akodad, M., Wood, D. A., Leipsic, J. A., Blanke, P., Dangas, G. D., Sharma, S. K., Kini, A. S., Webb, J. G., & Sathananthan, J. (2022). Outcomes and feasibility of redo‐TAVR after Sapien 3 Ultra TAVR in extremely‐undersized versus nominally‐sized annuli. Catheterization & Cardiovascular Interventions, 99(6), 1935–1944. https://doi.org/10.1002/ccd.30146

Chicago

Tang, Gilbert H. L., Amit Hooda, Syed Zaid, Ming‐Yu Chuang, Sahil Khera, Parasuram Krishnamoorthy, Stamatios Lerakis, et al. 2022. “Outcomes and Feasibility of Redo‐TAVR after Sapien 3 Ultra TAVR in Extremely‐undersized versus Nominally‐sized Annuli.” Catheterization & Cardiovascular Interventions 99 (6): 1935–44. doi:10.1002/ccd.30146.